If your clients or their parents live in long-term care facilities, they should be aware of efforts to find alternatives to antipsychotic drug prescriptions.
An Australia-based hedge fund manager has entered the fray over Valeant, alleging a vast web of dubious, Valeant-linked pharmacies with names only chess experts and Stephen King aficionados would recognize as forming a pattern.
Yesterday, shares of Valeant Pharmaceuticals International plunged as much as 20%.
Valeant CEO Mike Pearson dismisses criticism of his growth-through-acquisition strategy.
Canadians should press federal parties to discuss their positions on the quality of healthcare.
Liberal Leader Justin Trudeau is promising to lower the government's eligibility requirements for Canadians needing help to care for a sick loved one.
Since the introduction of the Affordable Care Act (ACA), U.S. healthcare companies have seen a boost in revenues and margins.
Aging boomers are fuelling explosive demand for innovative care
Manu's appointed a director of Pharmaceutical Relations to combat new challenges.
The healthcare sector has changed over the last few years.